Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along...
Uloženo v:
| Vydáno v: | Multiple sclerosis Ročník 23; číslo 5; s. 704 - 710 |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
01.04.2017
|
| Témata: | |
| ISSN: | 1477-0970 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with multiple sclerosis (MS). One of the MSOAC goals is acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful in MS. This article addresses the history, application, and psychometric properties of one such MSOAC metric of ambulation or walking namely, the timed 25-foot walk (T25FW). The T25FW has strong reliability over both brief and long periods of time in MS across a large range of disability levels. The outcome of walking speed from the T25FW has obvious real-world relevance and has correlated strongly with other measures of walking and lower extremity function. The T25FW is responsive for capturing intervention effects in pharmacological and rehabilitation trials and has an established value for capturing clinically meaningful change in ambulation. Directions for future research involve validating clinically meaningful improvements on the T25FW as well as determining whether 20% change is clinically meaningful across the disability spectrum. Researchers might further consider synchronizing accelerometers and motion sensors with the T25FW for capturing walking speed in everyday life and the patient's real environment. |
|---|---|
| AbstractList | The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with multiple sclerosis (MS). One of the MSOAC goals is acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful in MS. This article addresses the history, application, and psychometric properties of one such MSOAC metric of ambulation or walking namely, the timed 25-foot walk (T25FW). The T25FW has strong reliability over both brief and long periods of time in MS across a large range of disability levels. The outcome of walking speed from the T25FW has obvious real-world relevance and has correlated strongly with other measures of walking and lower extremity function. The T25FW is responsive for capturing intervention effects in pharmacological and rehabilitation trials and has an established value for capturing clinically meaningful change in ambulation. Directions for future research involve validating clinically meaningful improvements on the T25FW as well as determining whether 20% change is clinically meaningful across the disability spectrum. Researchers might further consider synchronizing accelerometers and motion sensors with the T25FW for capturing walking speed in everyday life and the patient's real environment. |
| Author | LaRocca, Nicholas Phillips, Glenn Benedict, Ralph Motl, Robert W Hudson, Lynn D Cohen, Jeffrey A Rudick, Richard |
| AuthorAffiliation | Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA |
| AuthorAffiliation_xml | – name: Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA |
| Author_xml | – sequence: 1 givenname: Robert W surname: Motl fullname: Motl, Robert W organization: Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, USA – sequence: 2 givenname: Jeffrey A surname: Cohen fullname: Cohen, Jeffrey A organization: Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA – sequence: 3 givenname: Ralph surname: Benedict fullname: Benedict, Ralph organization: Department of Neurology, University at Buffalo, Buffalo, NY, USA – sequence: 4 givenname: Glenn surname: Phillips fullname: Phillips, Glenn organization: Biogen, Cambridge, MA, USA – sequence: 5 givenname: Nicholas surname: LaRocca fullname: LaRocca, Nicholas organization: National Multiple Sclerosis Society, New York, NY, USA – sequence: 6 givenname: Lynn D surname: Hudson fullname: Hudson, Lynn D organization: Critical Path Institute, Tucson, AZ, USA – sequence: 7 givenname: Richard surname: Rudick fullname: Rudick, Richard organization: Biogen, Cambridge, MA, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28206828$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kE1LxDAURYMojjO6dyVZuqkmL22TLGXwCwbcqNuSpi9YTZrapMj8ewuOq7u4hwv3rMnxEAck5JKzG86lvOWigrJSFZe1ZgrEETnjpZQF05KtyDqlT8aYlKI6JStQwGoF6oy4d-P7rs97Gh3NH0hzH7CjUBUuxkx_jP-iJlEzUBPa2Zscpz0dcXJxCmawSOOcbQxIA5o0T0iXgobZ5370SJP1OMXUp3Ny4oxPeHHIDXl7uH_dPhW7l8fn7d2usJWAXGgnOqwlgOscZ9qq1qJwphQOwIiFaasSOlG3pYa205phx5w1kiG2WukSNuT6b3ec4veMKTehTxa9NwPGOTVcLXI01IIt6NUBndvlcjNOfTDTvvl3A7_EE2eM |
| CitedBy_id | crossref_primary_10_1007_s11332_019_00545_1 crossref_primary_10_1016_j_msard_2020_102390 crossref_primary_10_3390_s21093075 crossref_primary_10_1186_s12883_024_03871_1 crossref_primary_10_1136_bmjopen_2022_062160 crossref_primary_10_1177_13524585241260145 crossref_primary_10_1007_s00415_017_8676_8 crossref_primary_10_3390_s23073407 crossref_primary_10_3390_s21072259 crossref_primary_10_1016_j_msard_2021_103400 crossref_primary_10_1007_s00415_020_09759_7 crossref_primary_10_1016_j_msard_2022_104216 crossref_primary_10_1016_j_apmr_2025_05_005 crossref_primary_10_1016_j_msard_2022_103802 crossref_primary_10_1177_20552173211061547 crossref_primary_10_1212_WNL_0000000000213558 crossref_primary_10_3389_fneur_2018_00386 crossref_primary_10_1177_1352458519872465 crossref_primary_10_1212_WNL_0000000000207301 crossref_primary_10_1177_1352458519876701 crossref_primary_10_1002_acn3_51996 crossref_primary_10_1002_pri_70103 crossref_primary_10_1097_TGR_0000000000000233 crossref_primary_10_3389_fneur_2020_00700 crossref_primary_10_1016_j_gaitpost_2020_11_025 crossref_primary_10_3389_fneur_2018_00718 crossref_primary_10_1016_j_cct_2024_107584 crossref_primary_10_1016_j_msard_2023_104624 crossref_primary_10_1177_1352458517690825 crossref_primary_10_3389_fnhum_2021_639269 crossref_primary_10_1177_13524585211035333 crossref_primary_10_3389_fneur_2021_608491 crossref_primary_10_1016_j_msard_2023_105394 crossref_primary_10_7224_1537_2073_2023_108 crossref_primary_10_1186_s12984_023_01266_w crossref_primary_10_1155_2019_6430596 crossref_primary_10_3389_fneur_2024_1379712 crossref_primary_10_1016_j_msard_2023_104710 crossref_primary_10_1371_journal_pone_0220613 crossref_primary_10_1016_j_msard_2022_104433 crossref_primary_10_1007_s00415_023_12099_x crossref_primary_10_1007_s12325_019_00958_x crossref_primary_10_1016_j_trci_2019_06_007 crossref_primary_10_1080_00207454_2022_2090353 crossref_primary_10_3390_diagnostics15070936 crossref_primary_10_3389_fneur_2022_878313 crossref_primary_10_1111_ene_15163 crossref_primary_10_1111_jon_13064 crossref_primary_10_1186_s12883_020_1611_0 crossref_primary_10_1111_ane_13441 crossref_primary_10_1016_j_bandc_2025_106349 crossref_primary_10_1016_j_jocn_2020_10_034 crossref_primary_10_1177_20552173211015503 crossref_primary_10_3390_cells14130969 crossref_primary_10_3390_biom11091342 crossref_primary_10_3390_ijerph192416989 crossref_primary_10_1016_j_msard_2024_105679 crossref_primary_10_1109_JBHI_2020_2998187 crossref_primary_10_3389_fneur_2023_1172419 crossref_primary_10_1080_14737175_2018_1510772 crossref_primary_10_1016_j_msard_2019_06_019 crossref_primary_10_1155_ane_5593383 crossref_primary_10_1177_1352458517745725 crossref_primary_10_1007_s40273_020_00964_w crossref_primary_10_1177_13524585211017013 crossref_primary_10_1016_j_jelekin_2021_102607 crossref_primary_10_1016_j_msard_2024_105439 crossref_primary_10_1016_j_nicl_2021_102653 crossref_primary_10_1016_j_msard_2025_106380 crossref_primary_10_1177_15459683241260724 crossref_primary_10_1177_13524585231187283 crossref_primary_10_1016_j_cct_2019_04_013 crossref_primary_10_1177_1352458517723718 crossref_primary_10_1007_s00415_020_09965_3 crossref_primary_10_1111_ane_13313 crossref_primary_10_3390_cells8111439 crossref_primary_10_1177_13524585231152433 crossref_primary_10_1007_s00415_019_09500_z crossref_primary_10_1007_s40263_024_01132_w crossref_primary_10_1016_j_msard_2021_103165 crossref_primary_10_1016_j_msard_2025_106713 crossref_primary_10_3233_NRE_201535 crossref_primary_10_1080_09593985_2021_1978118 crossref_primary_10_1097_NPT_0000000000000529 crossref_primary_10_1177_13524585221094224 crossref_primary_10_1016_j_cct_2019_105878 crossref_primary_10_1080_10543406_2023_2280557 crossref_primary_10_1016_j_cct_2017_07_016 crossref_primary_10_1016_j_msard_2022_103842 crossref_primary_10_1016_j_jns_2024_123073 crossref_primary_10_1212_CPJ_0000000000000918 crossref_primary_10_1016_j_msard_2022_103725 crossref_primary_10_1016_j_msard_2022_103718 crossref_primary_10_1016_j_msard_2020_101941 crossref_primary_10_1002_sim_9625 crossref_primary_10_1177_15459683231206741 crossref_primary_10_1177_1352458520987539 crossref_primary_10_3389_fneur_2021_758710 crossref_primary_10_1159_000547176 crossref_primary_10_1016_j_msard_2025_106271 crossref_primary_10_1002_ana_26239 crossref_primary_10_1016_j_msard_2022_104242 crossref_primary_10_1038_s41582_024_01023_0 crossref_primary_10_1016_j_msard_2025_106722 crossref_primary_10_1016_j_neuropsychologia_2018_05_007 crossref_primary_10_1080_14737175_2025_2450788 crossref_primary_10_1111_ene_15220 crossref_primary_10_1186_s12938_022_00992_x crossref_primary_10_1007_s40263_018_0530_8 crossref_primary_10_1177_1352458518807076 crossref_primary_10_1371_journal_pone_0189281 crossref_primary_10_3389_fimmu_2024_1362629 crossref_primary_10_1097_NPT_0000000000000505 crossref_primary_10_3389_fneur_2023_1247532 crossref_primary_10_3390_app12147223 crossref_primary_10_1016_j_msard_2019_01_028 crossref_primary_10_1016_j_explore_2020_07_013 crossref_primary_10_1016_j_msard_2022_103702 crossref_primary_10_3390_brainsci15030274 crossref_primary_10_1016_j_cmpb_2022_107204 crossref_primary_10_1177_1352458517729465 crossref_primary_10_1212_WNL_0000000000213332 crossref_primary_10_1080_01616412_2025_2484426 crossref_primary_10_1016_j_conctc_2024_101279 crossref_primary_10_1177_2055217318783766 crossref_primary_10_1080_09593985_2023_2299726 crossref_primary_10_1177_1352458519881991 crossref_primary_10_1177_20552076231205284 crossref_primary_10_1016_j_heliyon_2022_e10259 crossref_primary_10_1186_s12955_023_02190_2 crossref_primary_10_3389_fneur_2017_00433 crossref_primary_10_1038_s41598_020_79095_3 crossref_primary_10_1038_s41598_025_10830_4 crossref_primary_10_1016_j_clinbiomech_2022_105826 crossref_primary_10_1371_journal_pone_0222288 crossref_primary_10_1212_CPJ_0000000000200184 crossref_primary_10_3389_fnbeh_2018_00296 crossref_primary_10_1159_000531860 crossref_primary_10_1016_j_msard_2018_08_020 crossref_primary_10_1016_S1474_4422_20_30277_5 crossref_primary_10_1016_j_apmr_2025_02_005 crossref_primary_10_1016_j_msard_2024_105598 crossref_primary_10_1111_ene_15920 crossref_primary_10_1111_nyas_14777 crossref_primary_10_1016_j_jns_2020_116978 crossref_primary_10_1177_13524585231187521 crossref_primary_10_7705_biomedica_6873 crossref_primary_10_1111_ene_14162 crossref_primary_10_1177_2055217317753465 crossref_primary_10_1177_13524585241274607 crossref_primary_10_14309_ajg_0000000000002630 crossref_primary_10_1016_j_jshs_2018_06_008 crossref_primary_10_1136_bmjopen_2024_097970 crossref_primary_10_3390_healthcare12010010 crossref_primary_10_1177_13524585221125372 crossref_primary_10_1016_j_msard_2021_103360 crossref_primary_10_1016_j_msard_2022_103640 crossref_primary_10_1016_j_msard_2022_103644 crossref_primary_10_1177_13524585231214362 crossref_primary_10_1177_1352458518796690 crossref_primary_10_1155_2024_4882755 crossref_primary_10_2196_44428 crossref_primary_10_3390_sclerosis3030022 crossref_primary_10_1177_1352458519898108 crossref_primary_10_1212_WNL_0000000000011863 crossref_primary_10_1212_WNL_0000000000011862 crossref_primary_10_1007_s13311_022_01246_3 crossref_primary_10_1097_WNP_0000000000000431 crossref_primary_10_3390_neurolint17070112 crossref_primary_10_1016_j_cct_2024_107621 crossref_primary_10_2196_30394 crossref_primary_10_2196_58026 crossref_primary_10_1016_j_msard_2022_103998 crossref_primary_10_1177_13524585241273054 crossref_primary_10_1038_s41582_019_0183_3 crossref_primary_10_1038_s41746_024_01025_8 crossref_primary_10_3390_ijerph18020498 crossref_primary_10_1038_s41598_018_22676_0 crossref_primary_10_1002_acn3_51354 crossref_primary_10_1016_j_msard_2022_103519 crossref_primary_10_1038_s41582_020_00448_7 crossref_primary_10_1212_CPJ_0000000000000382 crossref_primary_10_1080_09593985_2021_1931590 crossref_primary_10_3390_brainsci14030277 crossref_primary_10_1177_15459683251318246 crossref_primary_10_1089_jicm_2022_0610 crossref_primary_10_1186_s13104_023_06316_z crossref_primary_10_1038_s41598_020_69667_8 crossref_primary_10_1080_23279095_2018_1448818 crossref_primary_10_1038_s41598_021_92776_x crossref_primary_10_1016_j_jneuroim_2025_578613 crossref_primary_10_1038_s41598_025_05048_3 crossref_primary_10_1177_15459683221076461 crossref_primary_10_1097_WNN_0000000000000179 crossref_primary_10_1177_1352458520914822 crossref_primary_10_1016_j_msard_2023_104552 crossref_primary_10_3389_fneur_2025_1563041 crossref_primary_10_1186_s12883_023_03436_8 crossref_primary_10_1007_s00415_020_09696_5 crossref_primary_10_1177_13524585251335213 crossref_primary_10_7224_1537_2073_2023_091 crossref_primary_10_1177_1352458518754716 crossref_primary_10_3389_fnins_2020_582046 crossref_primary_10_7717_peerj_9303 crossref_primary_10_1016_j_apmr_2020_10_122 crossref_primary_10_3389_fnhum_2024_1449388 crossref_primary_10_1111_jnp_12285 crossref_primary_10_2147_DNND_S384038 crossref_primary_10_3390_s25061780 crossref_primary_10_1212_CON_0000000000000727 crossref_primary_10_1177_13524585211063623 crossref_primary_10_1097_NPT_0000000000000439 crossref_primary_10_1007_s00221_025_07156_y crossref_primary_10_3390_neurolint17050063 crossref_primary_10_7224_1537_2073_2021_130 crossref_primary_10_1093_ptj_pzaa227 crossref_primary_10_2196_19598 crossref_primary_10_1177_1545968317753681 crossref_primary_10_1016_j_msard_2024_105715 crossref_primary_10_3390_s23136017 crossref_primary_10_2217_nmt_2018_0016 crossref_primary_10_1177_1352458520983584 crossref_primary_10_1080_09638288_2018_1496154 crossref_primary_10_1159_000512513 crossref_primary_10_1177_1352458520936231 crossref_primary_10_1136_bmjopen_2024_085241 crossref_primary_10_1007_s00415_019_09489_5 crossref_primary_10_1186_s12883_023_03513_y crossref_primary_10_3389_fneur_2020_00735 crossref_primary_10_1007_s00415_022_11171_2 crossref_primary_10_1016_j_csbj_2025_05_003 crossref_primary_10_3233_NRE_182498 crossref_primary_10_1016_j_ncl_2023_07_002 crossref_primary_10_1016_j_jns_2023_122781 crossref_primary_10_7224_1537_2073_2018_001 crossref_primary_10_1186_s13102_023_00790_5 crossref_primary_10_3390_life13071501 crossref_primary_10_1152_jn_00373_2022 crossref_primary_10_1177_13524585231189671 crossref_primary_10_1016_j_msard_2025_106674 crossref_primary_10_1097_NPT_0000000000000497 crossref_primary_10_1177_15459683231167850 crossref_primary_10_1007_s00415_018_9075_5 crossref_primary_10_1016_j_msard_2022_104094 crossref_primary_10_1177_13524585241282763 crossref_primary_10_1007_s10548_021_00858_w crossref_primary_10_1007_s11910_019_0997_9 crossref_primary_10_1016_j_msard_2023_105354 crossref_primary_10_1016_j_msard_2024_105731 crossref_primary_10_1002_jmri_27389 crossref_primary_10_1080_01616412_2023_2252283 crossref_primary_10_1136_bmjopen_2020_043699 crossref_primary_10_3390_app14177906 crossref_primary_10_7224_1537_2073_2020_114 crossref_primary_10_1007_s00415_022_11306_5 crossref_primary_10_3390_brainsci12010063 crossref_primary_10_1007_s00415_025_13066_4 crossref_primary_10_1016_j_gaitpost_2025_03_011 crossref_primary_10_1080_01616412_2024_2338033 crossref_primary_10_1016_j_apmr_2023_06_019 crossref_primary_10_1016_j_msard_2020_102186 crossref_primary_10_1177_2055217320964940 crossref_primary_10_1136_bmjopen_2023_073782 crossref_primary_10_1177_13524585221105465 crossref_primary_10_1097_WCO_0000000000000928 crossref_primary_10_1177_20552173231202123 crossref_primary_10_1016_j_msard_2019_07_003 crossref_primary_10_1038_s41598_021_92353_2 crossref_primary_10_2196_63090 crossref_primary_10_1007_s00415_023_11945_2 crossref_primary_10_1016_j_msard_2021_102808 crossref_primary_10_1177_1352458518815795 crossref_primary_10_3390_app14146193 crossref_primary_10_1038_s41598_024_62726_4 crossref_primary_10_1177_13524585231190771 crossref_primary_10_1080_07853890_2023_2252439 crossref_primary_10_36290_neu_2022_032 crossref_primary_10_3389_fnins_2023_1231321 crossref_primary_10_1212_WNL_0000000000011123 crossref_primary_10_7224_1537_2073_2020_133 crossref_primary_10_1016_j_msard_2024_105630 crossref_primary_10_1109_JIOT_2025_3545744 crossref_primary_10_17826_cumj_631595 crossref_primary_10_3390_pharmacy8020061 crossref_primary_10_1007_s00415_021_10674_8 crossref_primary_10_3390_neurolint14020035 crossref_primary_10_1017_S1355617723000371 crossref_primary_10_1016_j_msard_2021_102946 crossref_primary_10_1177_20552173221099186 crossref_primary_10_1016_j_apmr_2019_08_488 crossref_primary_10_1212_WNL_0000000000012690 crossref_primary_10_1016_j_msard_2025_106343 crossref_primary_10_1212_WNL_0000000000008519 crossref_primary_10_3389_fneur_2022_907245 crossref_primary_10_1016_j_msard_2025_106462 crossref_primary_10_3390_biomedicines7030056 crossref_primary_10_1007_s00415_021_10750_z crossref_primary_10_1080_09602011_2018_1449758 |
| ContentType | Journal Article |
| CorporateAuthor | Multiple Sclerosis Outcome Assessments Consortium |
| CorporateAuthor_xml | – name: Multiple Sclerosis Outcome Assessments Consortium |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1177/1352458517690823 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1477-0970 |
| EndPage | 710 |
| ExternalDocumentID | 28206828 |
| Genre | Journal Article |
| GroupedDBID | --- -TM .2E .2F .2G .2J .2N 01A 0R~ 123 18M 1~K 29M 31R 31S 31U 31X 31Y 31Z 36B 39C 4.4 53G 54M 5VS 7X7 88E 8FI 8FJ 8R4 8R5 AABMB AABOD AACKU AACMV AACTG AADUE AAEWN AAGGD AAGMC AAJIQ AAJOX AAJPV AAKGS AANSI AAPEO AAQDB AAQXH AAQXI AARDL AARIX AATAA AATBZ AAUAS AAXOT AAYTG AAZBJ ABAFQ ABAWC ABAWP ABCCA ABCJG ABDWY ABEIX ABFWQ ABHFT ABHKI ABHQH ABJIS ABJNI ABKRH ABLUO ABNCE ABPGX ABPNF ABQKF ABQXT ABRHV ABUJY ABUWG ABVFX ABVVC ABYTW ACARO ACDSZ ACDXX ACFEJ ACFMA ACFYK ACGBL ACGFO ACGFS ACGZU ACJER ACJTF ACLFY ACLHI ACLZU ACNXM ACOFE ACOXC ACPRK ACROE ACRPL ACSIQ ACUAV ACUIR ACXKE ACXMB ADBBV ADDLC ADEIA ADMPF ADNBR ADNMO ADNON ADRRZ ADTBJ ADUCT ADUKL ADVBO ADYCS ADZYD ADZZY AECGH AECVZ AEDTQ AEKYL AENEX AEPTA AEQLS AERKM AESZF AEUHG AEWDL AEWHI AEXFG AEXNY AFEET AFKBI AFKRA AFKRG AFMOU AFQAA AFUIA AFVCE AFWMB AGHKR AGKLV AGNHF AGPXR AGWFA AGWNL AHDMH AHHFK AHMBA AIGRN AJABX AJEFB AJMMQ AJSCY AJUZI AJXAJ AJXGE ALIPV ALKWR ALMA_UNASSIGNED_HOLDINGS ALTZF AMCVQ ANDLU ARTOV ASPBG AUTPY AVWKF AYAKG AZFZN AZQEC B3H B8M B8O B8R B8Z B93 B94 BBRGL BDDNI BENPR BKIIM BKNYI BKSCU BPACV BPHCQ BSEHC BVXVI BWJAD BYIEH CAG CBRKF CCPQU CDWPY CFDXU CGR COF CORYS CQQTX CS3 CUTAK CUY CVF DB0 DC- DC0 DD- DD0 DE- DF0 DO- DOPDO DU5 DV7 DV9 D~Y EBS ECM EIF EJD EMOBN F5P FD6 FEDTE FHBDP FYUFA GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION H13 HF~ HMCUK HVGLF HZ~ J8X K.F K.J K9- M0R M1P M4V N9A NPM O9- P.B P2P PHGZT PQQKQ PROAC PSQYO Q1R Q2X Q7K Q7L Q7R Q7U Q7X Q82 Q83 ROL S01 SAUOL SCNPE SDB SFB SFC SFK SFN SFT SGA SGO SGP SGR SGV SGX SGZ SHG SNB SPJ SPQ SPV SQCSI STM UKHRP XJT ZONMY ZPPRI ZRKOI ZSSAH 7X8 AAPII ABIDT ABJZC ADEBD AJGYC AJHME AJVBE SASJQ |
| ID | FETCH-LOGICAL-c532t-9f3de6722fdf109c8bce3fa43f22a3c53b542d36b492bd990ed0fca70eeb98942 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 316 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000399859300013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| IngestDate | Sun Sep 28 02:44:31 EDT 2025 Thu Apr 03 06:56:50 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | validity Ambulation gait multiple sclerosis walking reliability |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c532t-9f3de6722fdf109c8bce3fa43f22a3c53b542d36b492bd990ed0fca70eeb98942 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://journals.sagepub.com/doi/full/10.1177/1352458517690823 |
| PMID | 28206828 |
| PQID | 1869092630 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_1869092630 pubmed_primary_28206828 |
| PublicationCentury | 2000 |
| PublicationDate | 2017-04-01 |
| PublicationDateYYYYMMDD | 2017-04-01 |
| PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Multiple sclerosis |
| PublicationTitleAlternate | Mult Scler |
| PublicationYear | 2017 |
| References | 28206813 - Mult Scler. 2017 Apr;23(5):626-627 |
| References_xml | – reference: 28206813 - Mult Scler. 2017 Apr;23(5):626-627 |
| SSID | ssj0007735 |
| Score | 2.6246998 |
| SecondaryResourceType | review_article |
| Snippet | The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA),... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 704 |
| SubjectTerms | Adult Disability Evaluation Exercise Test - methods Female Humans Male Middle Aged Multiple Sclerosis - physiopathology Multiple Sclerosis - rehabilitation Outcome Assessment (Health Care) Reproducibility of Results Walking - physiology |
| Title | Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/28206828 https://www.proquest.com/docview/1869092630 |
| Volume | 23 |
| WOSCitedRecordID | wos000399859300013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEA7qinjx_VhfRPAatknapD2JiIuXXfagsreSNAksartuu4r_3knbpSdB8NJLWxLSyXxfZybzIXRDtTCJsRmh4AlJKDQnccQkASSmgklmqIlrsQk5HsfTaTJpA25lW1a58om1ozZF5mPkg1o6KWGCB7fzD-JVo3x2tZXQWEc9DlTGW7Wcdt3CpeRRl5ocUCAboU-DSVELff9OKmtwGe7-d1p7aKellfiusYN9tGbzA7Q1ahPnh8i9AN82wLhx4TBwPuw15Q1mEXFFUeEv9faKVYlVjtW79opexeIbz7tDBbhYVjAhi9-bmCKGG3hVjIhLGBPQdlYeoefhw9P9I2klFkgWcVaRxHFjhWTMGUeDJIt1ZrlTIXeMKQ7P6ChkhgsdJkwbQC5rApcpGVirfet2dow28iK3pwgraoELxpbKzIZUOeUPImoDdEAkOuCyj65XK5iCCfu8hMptsSzTbg376KT5DOm86bWRMt9fHv4Kz_7w9jnaZh5067qaC9RzsIHtJdrMPqtZubiqbQOu48noB0UNxdM |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validity+of+the+timed+25-foot+walk+as+an+ambulatory+performance+outcome+measure+for+multiple+sclerosis&rft.jtitle=Multiple+sclerosis&rft.au=Motl%2C+Robert+W&rft.au=Cohen%2C+Jeffrey+A&rft.au=Benedict%2C+Ralph&rft.au=Phillips%2C+Glenn&rft.date=2017-04-01&rft.eissn=1477-0970&rft.volume=23&rft.issue=5&rft.spage=704&rft.epage=710&rft_id=info:doi/10.1177%2F1352458517690823&rft.externalDBID=NO_FULL_TEXT |